For citations:
Gorbunova V.A., Orlov S.V., Zyryanov S.K., Belousov D.Yu. Pharmacoeconomic analysis of Giotrif® (afatinib) as first-line treatment of metastatic non-small cell lung cancer with Del19 mutation of epidermal growth factor receptor (EGFR) gene. Malignant tumours. 2015;(4):35-47. (In Russ.) https://doi.org/10.18027/2224-5057-2015-4-35-47
Views PDF (Rus): 1033
Email this article 